JJ
Johnson & Johnson’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136M | Hold |
2,449,183
| – | – | 40.83% | 1 |
|
|
2025
Q1 | $118M | Hold |
2,449,183
| – | – | 34.65% | 1 |
|
|
2024
Q4 | $94.5M | Hold |
2,449,183
| – | – | 24.48% | 1 |
|
|
2024
Q3 | $110M | Hold |
2,449,183
| – | – | 25.79% | 1 |
|
|
2024
Q2 | $84.9M | Hold |
2,449,183
| – | – | 21.18% | 1 |
|
|
2024
Q1 | $70.9M | Hold |
2,449,183
| – | – | 1.61% | 4 |
|
|
2023
Q4 | $56.2M | Hold |
2,449,183
| – | – | 1.28% | 3 |
|
|
2023
Q3 | $40.9M | Hold |
2,449,183
| – | – | 15.05% | 3 |
|
|
2023
Q2 | $67.6M | Hold |
2,449,183
| – | – | 21% | 1 |
|
|
2023
Q1 | $56.3M | Hold |
2,449,183
| – | – | 18.32% | 2 |
|
|
2022
Q4 | $26.7M | Hold |
2,449,183
| – | – | 7.77% | 5 |
|
|
2022
Q3 | $20.6M | Hold |
2,449,183
| – | – | 6.08% | 6 |
|
|
2022
Q2 | $19.4M | Hold |
2,449,183
| – | – | 4.95% | 8 |
|
|
2022
Q1 | $58M | Hold |
2,449,183
| – | – | 10.96% | 3 |
|
|
2021
Q4 | $83.8M | Hold |
2,449,183
| – | – | 9.54% | 3 |
|
|
2021
Q3 | $43.4M | Buy |
+2,449,183
| New | +$43.4M | 3.81% | 7 |
|